Möchten Sie immer auf dem neuesten Stand bleiben?

(Figures in brackets refer to the corresponding period last year) 8 May 2024 – Prosafe SE reported EBITDA of USD 7.2 million (negative USD 6.4 million) for the first quarter of 2024. The...

May 8, 2024 Highlights Year-to-date Directional1 revenue of US$871 million, in line with expectationFull year 2024 Directional revenue and Directional EBITDA guidance maintainedCash dividend of...

First quarter 2024 revenues increased by 31% to US$55.6 million, compared to the first quarter 2023, driven by the U.S. commercial launch of Joenja® and revenue growth of RUCONEST®RUCONEST® revenues...

SIMPLIFYING THE BUSINESS AND 100 PER CENT PAYOUT HIGHLIGHTS EBITDA of USD 31.3m including USD 4.7m from Lighthouse NavigationNet result of USD 15.7mDeclared dividend of NOK 0.60 per share – 100...

LONDON, 08 May. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...

Oslo, 8 May 2024 – DNO ASA, the Norwegian oil and gas operator, today announced that the Company’s wholly-owned subsidiary DNO Norge AS has entered into an agreement to acquire stakes in five oil and...

Good start to 2024 Highlights Q1 2024 Produced Revenues of $222.6 million, compared to $172.2 million in Q1 2023Produced EBITDA of $112.5 million, compared to $71.5 million in Q1 2023Produced...

Geneva, Switzerland, May 8, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO,...

Oslo, 8 May 2024 - DNO ASA, the Norwegian oil and gas operator, today announced that pursuant to the authorization granted at the Annual General Meeting held on 25 May 2023, the Board of Directors has...

Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024 Halle (Saale) / Munich, Germany, May 08, 2024 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...